Fluctuating Parkinson's Disease
- 1 December 1994
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 51 (12) , 1236-1241
- https://doi.org/10.1001/archneur.1994.00540240080020
Abstract
From JAMA Neurology — Fluctuating Parkinson's Disease — Treatment With the Eong-Acting Dopamine Agonist CabergolineKeywords
This publication has 6 references indexed in Scilit:
- Controlled study of the antiparkinsonian activity and tolerability of cabergolineNeurology, 1993
- In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphineEuropean Journal of Pharmacology, 1990
- Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonistsEuropean Journal of Pharmacology, 1989
- Control of on/off phenomenon by continuous intravenous infusion of levodopaNeurology, 1984
- A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injectionsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1983
- Interaction of pergolide with central dopaminergic receptors.Proceedings of the National Academy of Sciences, 1980